These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19823032)
1. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development. Hviid L Hum Vaccin; 2010 Jan; 6(1):84-9. PubMed ID: 19823032 [TBL] [Abstract][Full Text] [Related]
2. Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Jensen AR; Adams Y; Hviid L Immunol Rev; 2020 Jan; 293(1):230-252. PubMed ID: 31562653 [TBL] [Abstract][Full Text] [Related]
3. Towards a vaccine against pregnancy-associated malaria. Tuikue Ndam N; Deloron P Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733 [TBL] [Abstract][Full Text] [Related]
4. Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates. Chan JA; Fowkes FJ; Beeson JG Cell Mol Life Sci; 2014 Oct; 71(19):3633-57. PubMed ID: 24691798 [TBL] [Abstract][Full Text] [Related]
5. VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria. Hviid L; Salanti A Parasitology; 2007; 134(Pt 13):1871-6. PubMed ID: 17958922 [TBL] [Abstract][Full Text] [Related]
6. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701 [TBL] [Abstract][Full Text] [Related]
7. The naturally acquired immunity in severe malaria and its implication for a PfEMP-1 based vaccine. Chen Q Microbes Infect; 2007 May; 9(6):777-83. PubMed ID: 17398133 [TBL] [Abstract][Full Text] [Related]
8. Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. Ghumra A; Semblat JP; Ataide R; Kifude C; Adams Y; Claessens A; Anong DN; Bull PC; Fennell C; Arman M; Amambua-Ngwa A; Walther M; Conway DJ; Kassambara L; Doumbo OK; Raza A; Rowe JA PLoS Pathog; 2012; 8(4):e1002665. PubMed ID: 22532802 [TBL] [Abstract][Full Text] [Related]
9. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A. Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE Malar J; 2004 Sep; 3():31. PubMed ID: 15350207 [TBL] [Abstract][Full Text] [Related]
10. Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. Barfod L; Bernasconi NL; Dahlbäck M; Jarrossay D; Andersen PH; Salanti A; Ofori MF; Turner L; Resende M; Nielsen MA; Theander TG; Sallusto F; Lanzavecchia A; Hviid L Mol Microbiol; 2007 Jan; 63(2):335-47. PubMed ID: 17176260 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275 [TBL] [Abstract][Full Text] [Related]
14. The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine. Bull PC; Abdi AI Parasitology; 2016 Feb; 143(2):171-86. PubMed ID: 26741401 [TBL] [Abstract][Full Text] [Related]
15. Development of vaccines against Plasmodium falciparum malaria: taking lessons from naturally acquired protective immunity. Hviid L Microbes Infect; 2007 May; 9(6):772-6. PubMed ID: 17398137 [TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of ID1-DBL2X predicts its validity as a vaccine candidate in Colombia and supports at least two independently introduced Plasmodium falciparum populations in the region. Rajwani J; Klinger CM; Arango E; Arroyo MI; Sabbagh A; Maestre A; Dacks JB; Gnidehou S; Yanow SK Infect Genet Evol; 2017 Nov; 55():175-185. PubMed ID: 28893687 [TBL] [Abstract][Full Text] [Related]
17. Evasion of Classical Complement Pathway Activation on Larsen MD; Quintana MDP; Ditlev SB; Bayarri-Olmos R; Ofori MF; Hviid L; Garred P Front Immunol; 2018; 9():3088. PubMed ID: 30666256 [TBL] [Abstract][Full Text] [Related]
18. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets? Sutherland CJ Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726 [TBL] [Abstract][Full Text] [Related]